ES014
1 abstract
Abstract
Preclinical characterization of a novel anti-CD39/TGFβ-trap bispecific antibody that aims to modulate tumor microenvironment.Org: Elpiscience Biopharma, Inc., Elpiscience Biopharma, Department of Medical Oncology, Shanghai Chest Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China, Department of Medical Oncology, Shanghai Chest Hospital, Jiao Tong University,